1. Home
  2. Analysis
  3. Compazine
  4. Levocarnitine

Compazine and Levocarnitine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Compazine and Levocarnitine. Common interactions include blood pressure increased among females and death among males.

The phase IV clinical study analyzes what interactions people who take Compazine and Levocarnitine have. It is created by eHealthMe based on reports of 9 people who take Compazine and Levocarnitine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 27, 2023

9 people who take Compazine and Levocarnitine together, and have interactions are studied.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 11,943 Compazine users for its effectiveness, alternative drugs and more.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 2,363 Levocarnitine users for its effectiveness, alternative drugs and more.

Number of Compazine and Levocarnitine reports submitted per year:

Compazine and Levocarnitine drug interactions.

Common Compazine and Levocarnitine drug interactions by gender *:

female:

  1. Blood pressure increased
  2. Constipation
  3. Dizziness
  4. Nausea
  5. Pruritus
  6. Vision blurred
  7. Bone marrow disorder
  8. Full blood count decreased
  9. Platelet count decreased
  10. White blood cell disorder

male:

  1. Death
  2. Depression
  3. Nausea
  4. Pancreatic mass
  5. Red blood cell count decreased
  6. Stomatitis
  7. Dermatitis allergic
  8. Diarrhoea
  9. Fatigue
  10. Hair colour changes

Common Compazine and Levocarnitine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Platelet count decreased
  2. White blood cell disorder
  3. Dyspnoea
  4. Insomnia
  5. Depression
  6. Diarrhoea
  7. Fatigue
  8. Hair colour changes
  9. Hypertension
  10. Impaired healing

60+:

  1. Death
  2. Dermatitis allergic

* Approximation only. Some reports may have incomplete information.

Do you take Compazine and Levocarnitine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Compazine and Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Compazine side effects:

Browse all side effects of Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levocarnitine side effects:

Browse all side effects of Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Compazine interactions:

Browse all interactions between Compazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levocarnitine interactions:

Browse all interactions between Levocarnitine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on prochlorperazine maleate and levocarnitine (the active ingredients of Compazine and Levocarnitine, respectively), and Compazine and Levocarnitine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Compazine and Levocarnitine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.